Optimising on-treatment review schedules: A narrative review of acute toxicities in ultra-hypofractionated stereotactic ablative body radiotherapy (SABR) for localised prostate cancer

Understanding the timing and pattern of acute toxicities can support radiotherapy teams in designing evidence-based review schedules, improving early detection of side effects, guiding patient education, and ensuring timely symptom management during SABR pathways.